Cytotoxic and cancerostatis activity of isothiocyanates and related compounds. I. Activity of some naturally occurring isothiocyanates and their synthetic analogues on HeLa-cells. 1968

K Horáková, and L Drobnica, and P Nemec, and A Antos, and P Kristián

UI MeSH Term Description Entries
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013861 Thiocyanates Organic derivatives of thiocyanic acid which contain the general formula R-SCN. Rhodanate,Rhodanates
D046508 Culture Techniques Methods of maintaining or growing biological materials in controlled laboratory conditions. These include the cultures of CELLS; TISSUES; organs; or embryo in vitro. Both animal and plant tissues may be cultured by a variety of methods. Cultures may derive from normal or abnormal tissues, and consist of a single cell type or mixed cell types. Culture Technique,Technique, Culture,Techniques, Culture

Related Publications

K Horáková, and L Drobnica, and P Nemec, and A Antos, and P Kristián
July 1967, Applied microbiology,
K Horáková, and L Drobnica, and P Nemec, and A Antos, and P Kristián
July 1968, Metabolism: clinical and experimental,
K Horáková, and L Drobnica, and P Nemec, and A Antos, and P Kristián
May 2002, Die Pharmazie,
K Horáková, and L Drobnica, and P Nemec, and A Antos, and P Kristián
January 1970, Acta morphologica Academiae Scientiarum Hungaricae,
K Horáková, and L Drobnica, and P Nemec, and A Antos, and P Kristián
April 1983, Xenobiotica; the fate of foreign compounds in biological systems,
K Horáková, and L Drobnica, and P Nemec, and A Antos, and P Kristián
December 2008, Journal of medicinal chemistry,
K Horáková, and L Drobnica, and P Nemec, and A Antos, and P Kristián
January 1982, Advances in experimental medicine and biology,
K Horáková, and L Drobnica, and P Nemec, and A Antos, and P Kristián
May 2018, Bioorganic & medicinal chemistry letters,
K Horáková, and L Drobnica, and P Nemec, and A Antos, and P Kristián
January 1995, BioFactors (Oxford, England),
K Horáková, and L Drobnica, and P Nemec, and A Antos, and P Kristián
July 1965, The Journal of antibiotics,
Copied contents to your clipboard!